Similar articles

• [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].

  Gutkowski K, Gutkowska D, Bilkiewicz T. Gutkowski K, et al. Przegl Lek. 2007;64(3):148-52. Przegl Lek. 2007. PMID: 17941466 Review. Polish.
• The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.

  Krupińska J, Wawrzynowicz-Syczewska M, Urbanowicz W, Pobłocki J, Syrenicz A. Krupińska J, et al. Endokrynol Pol. 2011;62(6):517-22. Endokrynol Pol. 2011. PMID: 22144218
• [Painless subacute thyroiditis with negative antithyroid antibodies during alpha interferon treatment in chronic hepatitis C].

  Mauri S, Puig J, Martínez-Riquelme A. Mauri S, et al. Med Clin (Barc). 1999 Nov 13;113(16):636. Med Clin (Barc). 1999. PMID: 10609261 Spanish. No abstract available.
• Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.

  Pellicano R, Smedile A, Peyre S, Astegiano M, Saracco G, Bonardi R, Rizzetto M. Pellicano R, et al. Minerva Gastroenterol Dietol. 2005 Mar;51(1):55-61. Minerva Gastroenterol Dietol. 2005. PMID: 15756146
• Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.

  Koh LK, Greenspan FS, Yeo PP. Koh LK, et al. Thyroid. 1997 Dec;7(6):891-6. doi: 10.1089/thy.1997.7.891. Thyroid. 1997. PMID: 9459633 Review.